Corvus Pharmaceuticals
CRVS
CRVS
52 hedge funds and large institutions have $212M invested in Corvus Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
41% less capital invested
Capital invested by funds: $360M → $212M (-$148M)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$9.74M | |
| 2 | +$5.75M | |
| 3 | +$3.32M | |
| 4 |
BlackRock
New York
|
+$2.31M |
| 5 |
JPMorgan Chase & Co
New York
|
+$2.16M |
Top Sellers
| 1 | -$13M | |
| 2 | -$5.46M | |
| 3 | -$2.79M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$2.53M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.13M |